Heron Therapeutics, Inc. (HRTX) Financials

HRTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 246.2 million 237.1 million
Dec. 31, 2025 255.9 million 241.5 million
Sept. 30, 2025 249.0 million 234.1 million
June 30, 2025 232.1 million 259.3 million

HRTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.9 million 3.0 million
Dec. 31, 2025 -9.2 million 2.2 million
Sept. 30, 2025 1.3 million 2.9 million
June 30, 2025 -11.1 million 2.8 million

HRTX Net Income

No data available :(

HRTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 44.8 million 141.6 million -
Dec. 31, 2025 46.6 million 140.6 million -
Sept. 30, 2025 55.5 million 139.7 million 780000
June 30, 2025 40.6 million - 1.5 million

HRTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 189.6 million
Dec. 31, 2025 166.7 million
Sept. 30, 2025 170.3 million
June 30, 2025 154.0 million

HRTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 391000 2.4 million 26.5 million 14.3 million
Dec. 31, 2025 - 3.7 million 25.7 million 12.2 million
Sept. 30, 2025 - 3.5 million 26.9 million 12.9 million
June 30, 2025 208000 2.9 million 26.0 million 11.6 million

HRTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 34.7 million 10.6 million
Dec. 31, 2025 40.6 million 7.6 million
Sept. 30, 2025 38.2 million 15.4 million
June 30, 2025 37.2 million 9.9 million

HRTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

HRTX

Price: $0.42

52 week price:
0.42
2.30

Earnings Per Share: -0.18 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4.0 million

Ebitda: -40.9 million

Market Capitalization: 70.4 million

Links: